Summary:A pilot clinical trial led by NYU Langone Health psychiatrists and biomedical engineers reveals that non-invasive transcranial ultrasound stimulation directed at the globus pallidus interna safely reduces delusions in individuals with schizophrenia and schizoaffective disorder. A single 10-minute session produced a clear, statistically meaningful decrease in delusion severity that persisted for up to one week compared to sham treatment, without significant adverse effects.Key Facts:Non-Invasive Deep Circuit Modulation: Using MRI-guided transcranial ultrasound stimulation, researchers delivered focused acoustic energy to the globus pallidus interna, a deep basal ganglia hub linked...
In Nature Neuroscience, UConn School of Medicine researchers have revealed a new scientific clue that could unlock the key cellular pathway leading to...
Microglia, the brain's immune cells, usually serve as diligent guardians. They eliminate intruders such as microbes and clear away cellular debris -- including...